APA
Dardaei L., Wang H. Q., Singh M., Fordjour P., Shaw K. X., Yoda S., Kerr G., Yu K., Liang J., Cao Y., Chen Y., Lawrence M. S., Langenbucher A., Gainor J. F., Friboulet L., Dagogo-Jack I., Myers D. T., Labrot E., Ruddy D., Parks M., Lee D., DiCecca R. H., Moody S., Hao H., Mohseni M., LaMarche M., Williams J., Hoffmaster K., Caponigro G., Shaw A. T., Hata A. N., Benes C. H., Li F. & Engelman J. A. (20190520). SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors. : Nature medicine.
Chicago
Dardaei Leila, Wang Hui Qin, Singh Manrose, Fordjour Paul, Shaw Katherine X, Yoda Satoshi, Kerr Grainne, Yu Kristine, Liang Jinsheng, Cao Yichen, Chen Yan, Lawrence Michael S, Langenbucher Adam, Gainor Justin F, Friboulet Luc, Dagogo-Jack Ibiayi, Myers David T, Labrot Emma, Ruddy David, Parks Melissa, Lee Dana, DiCecca Richard H, Moody Susan, Hao Huaixiang, Mohseni Morvarid, LaMarche Matthew, Williams Juliet, Hoffmaster Keith, Caponigro Giordano, Shaw Alice T, Hata Aaron N, Benes Cyril H, Li Fang and Engelman Jeffrey A. 20190520. SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors. : Nature medicine.
Harvard
Dardaei L., Wang H. Q., Singh M., Fordjour P., Shaw K. X., Yoda S., Kerr G., Yu K., Liang J., Cao Y., Chen Y., Lawrence M. S., Langenbucher A., Gainor J. F., Friboulet L., Dagogo-Jack I., Myers D. T., Labrot E., Ruddy D., Parks M., Lee D., DiCecca R. H., Moody S., Hao H., Mohseni M., LaMarche M., Williams J., Hoffmaster K., Caponigro G., Shaw A. T., Hata A. N., Benes C. H., Li F. and Engelman J. A. (20190520). SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors. : Nature medicine.
MLA
Dardaei Leila, Wang Hui Qin, Singh Manrose, Fordjour Paul, Shaw Katherine X, Yoda Satoshi, Kerr Grainne, Yu Kristine, Liang Jinsheng, Cao Yichen, Chen Yan, Lawrence Michael S, Langenbucher Adam, Gainor Justin F, Friboulet Luc, Dagogo-Jack Ibiayi, Myers David T, Labrot Emma, Ruddy David, Parks Melissa, Lee Dana, DiCecca Richard H, Moody Susan, Hao Huaixiang, Mohseni Morvarid, LaMarche Matthew, Williams Juliet, Hoffmaster Keith, Caponigro Giordano, Shaw Alice T, Hata Aaron N, Benes Cyril H, Li Fang and Engelman Jeffrey A. SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors. : Nature medicine. 20190520.